Matrix metalloproteinase-9 potentiates early brain injury after subarachnoid hemorrhage

62Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objective: This study investigated the role of matrix metalloproteinase-9 (MMP-9) in early brain injury after subarachnoid hemorrhage (SAH). Method: Sprague-Dawley male rats (n=36) weighing between 250 and 300 g were used. SAH was produced by injecting autologous arterial blood into the pre-chiasmatic cistern. MMP-9 protein expression and activity were measured by Western blot and zymogram; laminin expression and neuronal cell in hippocampus were studied by immunohistochemistry and TUNEL staining at 24 hours after SAH in the presence or absence of a selective MMP-9 inhibitor SB-3CT. Result: MMP-9 was activated by SAH and inhibited by SB-3CT at 24 hours after SAH (p<0.01). Laminin, the substrate of MMP-9, was decreased at 24 hours after SAH, and SB-3CT prevented laminin degradation. The number of TUNEL-positive neurons in hippocampus was increased after SAH and decreased by SB-3CT (p<0.01). In addition, brain water content and neurological functional abnormalities were attenuated by SB-3CT. Conclusion: MMP-9 may be involved in early brain injury through degradation of laminin and neuronal death, and inhibition of MMP-9 may be a potential direction for brain protection after SAH. © 2010 Maney Publishing.

Cite

CITATION STYLE

APA

Guo, Z., Sun, X., He, Z., Jiang, Y., Zhang, X., & Zhang, J. H. (2010). Matrix metalloproteinase-9 potentiates early brain injury after subarachnoid hemorrhage. Neurological Research, 32(7), 715–720. https://doi.org/10.1179/016164109X12478302362491

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free